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Abstract
Purpose.
Microaneurysms (MAs) are considered a hallmark of retinal vascular
disease, yet what little is known about them is mostly based upon histology,
not clinical observation. Here, we use the recently developed adaptive optics
scanning light ophthalmoscope (AOSLO) fluorescein angiography (FA) to
image human MAs in vivo and to expand on previously described MA
morphologic classification schemes.

Methods.
Patients with vascular retinopathies (diabetic, hypertensive, and
branch and central retinal vein occlusion) were imaged with reflectance
AOSLO and AOSLO FA. Ninety-three MAs, from 14 eyes, were imaged and
classified according to appearance into six morphologic groups: focal bulge,
saccular, fusiform, mixed, pedunculated, and irregular. The MA perimeter,
area, and feret maximum and minimum were correlated to morphology and
retinal pathology. Select MAs were imaged longitudinally in two eyes.

Results.
Adaptive optics scanning light ophthalmoscope fluorescein angiography
imaging revealed microscopic features of MAs not appreciated on conventional
images. Saccular MAs were most prevalent (47%). No association was found
between the type of retinal pathology and MA morphology (P = 0.44).
Pedunculated and irregular MAs were among the largest MAs with average
areas of 4188 and 4116 μm2, respectively. Focal hypofluorescent regions
were noted in 30% of MAs and were more likely to be associated with larger
MAs (3086 vs. 1448 μm2, P = 0.0001).

Conclusions.
Retinal MAs can be classified in vivo into six different morphologic
types, according to the geometry of their two-dimensional (2D) en face view.
Adaptive optics scanning light ophthalmoscope fluorescein angiography
imaging of MAs offers the possibility of studying microvascular change on a
histologic scale, which may help our understanding of disease progression and
treatment response.

Keywords: microaneurysm, AOSLO, fluorescein angiography
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Introduction
Initially described in diabetes, MAs appear as manifestations of
a wide range of systemic and retinal diseases, including ischemic,
infectious, inflammatory, hematologic, and radiation-related
disorders.1–5 Retinal MAs have been shown to be an important sign in
the progression of systemic disease,6–12 and they have been used as
components of multiple retinopathy severity classification schemes.13–
16
Microaneurysm counting17–21 and dynamic turnover22–25 studies have
revealed associations linking MAs to increased retinopathy, suggesting
that even a single MA may have predictive value.26 Furthermore,
clinical imaging has demonstrated that MAs are correlated with
extravascular leakage and vision loss.23,27
Despite their clinical significance, the pathogenesis and natural
history of individual MAs remains poorly understood. Histologic studies
using India ink infusion and trypsin digest techniques have
investigated the role of pericytes,28,29 lipid and hyaline infiltration,2,30
neovascularization,31 and endothelial disruption32 in attempts to
understand MA formation and progression. The relationship between
the MA wall and lumen has been investigated using trypsin digest
processing,33 electron microscopy,34 and confocal scanning laser
microscopy with von Willebrand factor staining.35 One recent study has
suggested that MA radius-to-associated-vessel-diameter ratio may be
a useful metric for stratifying risk of leakage,36 helping to explain why
some smaller MAs lead to leakage while some larger ones do not. As
treatment modalities advance to target individual MAs with laser
therapy,37 the ability to determine which MAs are at higher risk for
leakage or rupture is increasingly valuable. However, since most MA
knowledge is derived from post mortem histopathology, we currently
have a very limited understanding of the dynamics of MA development
and natural progression in vivo.
Advances in retinal imaging have increased our ability to image
the retinal vasculature, including the development of time-differential
fundus photography,38–40 optical coherence tomography (OCT),41–46
and entoptic viewing.47–49 A recent study using spectral-domain OCT
(SD-OCT) was able to extract basic MA dimensions through diameter
measurements.50 The correction of the ocular monochromatic
aberrations using adaptive optics, when added to the fundus
camera,51,52 scanning light ophthalmoscope (AOSLO),53–57 and OCT
(AO-OCT),58,59 has further improved our capacity to study healthy and
diseased microvasculature anatomy. Recently, we demonstrated that
in vivo imaging of the healthy human retinal microvasculature could be
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performed with safe light levels by combining AOSLO with fluorescein
angiography (AOSLO FA).60
Studying MAs with the resolution of AOSLO technology has the
potential to reveal helpful information about their formation, natural
progression, and response to treatment. In this manuscript, we use
AOSLO FA to expand upon previous MA classification schemes35,52 and
to introduce qualitative and quantitative metrics to describe MA
geometry in vivo. Using the complementary aspect of AOSLO
reflectance imaging, we investigated MA capillary wall and lumen
relationships as well as regions of MA and capillary nonperfusion. The
associations between MA morphology, size, and luminal fluorescence
were evaluated statistically.

Methods
Human Subjects
To ensure that the MA classification scheme presented here was
comprehensive and applicable to different pathologies, subjects with
various vascular retinopathies and ophthalmic treatment histories were
recruited. Ophthalmic diagnoses were established for each patient
based upon review of their medical records by New York Eye and Ear
Infirmary ophthalmologists. The presence of retinal MAs had been
previously documented by color fundus photography (Topcon 3D OCT
2000; Topcon Corporation, Tokyo, Japan) and/or standard FA (Topcon
3D OCT 2000; Topcon Corporation; Optos P200; Optos plc,
Dunfermline, Scotland; and Heidelberg Spectralis HRA-OCT;
Heidelberg Engineering, Inc., Heidelberg, Germany). Following
discussion of the nature and possible consequences of the study,
informed written consent was obtained from each subject. This study
adhered to the tenets of the Declaration of Helsinki and was approved
by the institutional review board of the New York Eye and Ear
Infirmary.

AOSLO Imaging Protocol
Mydriasis and cycloplegia were achieved by instillation of one
drop of 2.5% phenylephrine hydrochloride ophthalmic solution (Bausch
& Lomb, Inc., Rochester, NY) and one drop of 1% tropicamide
ophthalmic solution (Akorn, Inc., Lake Forest, IL). Ocular axial length
measurements were collected (IOL Master; Carl Zeiss Meditec AG,
Jena, Germany) in order to calculate the scale of the AOSLO images
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using the Emsley schematic eye model.61 The AOSLO used in this
study was a modified version of the one originally described by Dubra
and Sulai62 with the addition of a 488-nm light source, an emission
filter centered at 525 nm, and a 45-nm transmission bandwidth. The
subjects were positioned in front of the instrument using a dental
impression made with dental putty (Splash! Putty; DenMat Holdings,
LLC, Lompoc, CA) on a bite bar mounted on a translation stage. Fine
adjustments of the stage allowed for stable and repeatable alignment
of the subject's pupil with the entrance pupil of the AOSLO (7.75 mm
in diameter). Subjects were instructed to direct their gaze toward an
internal fixation target that was moved until the desired region of
interest was within the AOSLO field of view. These areas, all located
within 15° from the center of the fovea, contained microangiopathic
features previously identified on color fundus photography and/or
standard FA. The reflectance channel was used to scout important
regions to be examined with the fluorescence channel following
fluorescein administration.
Adaptive optics scanning light ophthalmoscope fluorescein
angiography imaging was performed using our previously described
protocol,60 after administering fluorescein at 20 mg/kg of body weight
in 50 mL of orange juice. Imaging was initiated at 15 minutes
following ingestion. Simultaneous image sequences of fluorescence
and reflectance images, consisting of up to 500 frames each, were
recorded at 15 frames/s using either a 1.0°, 1.5°, or 1.75° field of
view. Subjects were given short breaks at regular intervals and
encouraged to blink frequently to maintain normal tear film. Imaging
sessions concluded once all regions of interest had been imaged, the
patient tired, or the image signal waned. No imaging session extended
longer than 45 minutes. The feasibility of studying MA dynamics was
explored through longitudinal imaging at 1-month intervals in two
subjects.

Light Safety
During AOSLO imaging, the retina was simultaneously scanned
with three light sources, with wavelengths centered at 488, 790, and
850 nm. These light sources were coaxial and entered the eye with
collimation accounting for the longitudinal chromatic aberration of an
average eye. The three beams overlapped producing a square raster,
30% larger than the imaged area, using a 14.5-KHz horizontal
resonant optical scanner (Electro-Optical Products Corporation, New
York, NY) and a 16-Hz vertical scanner (Physik Instrumente,
Karlsruhe, Germany). Synchronous modulation of the light sources
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turned them on at the beginning of each horizontal line used for
imaging when scanning from left to right. As a result, only the central
portion of the scanning raster was exposed to light. The optical powers
without modulation (i.e., continuous wave) measured at the cornea
were 15 μW for the 850-nm wavefront sensing superluminescent diode
(SLD; Superlum, Carrigtwohill, Ireland), 210 μW for the 790-nm
imaging SLD (Superlum), and 32 μW for the 488-nm diode laser
(Lasos, Lasertechnick GmbH, Jena, Germany). During imaging, the
on/off modulation reduced the average powers delivered by
approximately 75%. No retinal location was exposed to the combined
light sources for longer than 120 seconds. All sources were considered
as lasers for calculating maximum permissible exposure (MPE) under
the American National Standards I (ANSI) Z136.1 2000 guidelines.63
These imaging parameters, as described above, resulted in light
exposures six times below both the photochemical and the thermal
MPE limits. In order to avoid any possibility for light or fluorescein
toxicity, repeat imaging sessions were performed after at least a 7-day
interval.

Image Processing
The reflectance image sequences, collected using 790-nm light,
were used to estimate eye motion64 in order to create a single
registered average image with high signal-to-noise ratio from each
image sequence. The AOSLO reflectance and fluorescence images
included in this manuscript were created in this manner, using
sequences of 32 to 100 frames after compensation of the warping due
to the sinusoidal motion of the resonant scanner. Registered images
were manually tiled (Adobe Photoshop CS6; Adobe Systems, Inc., San
Jose, CA) to create larger montages of the retinal vasculature, as
needed.

Microaneurysm Classification
The qualitative morphologic classification of MAs proposed in
this work is an extension of the scheme suggested by Moore et al.35
Reflectance AOSLO images were often obscure in subjects with
extensive vascular pathology, preventing interpretable visualization of
vascular features, while AOSLO FA was often able to clarify these
complex vascular relationships. The variation in longitudinal chromatic
aberration across individuals prevented both reflectance and
fluorescence images from being in focus at the same time for all
subjects.
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There were 93 MAs identified and classified according to their
two-dimensional (2D) geometry in the en face AOSLO FA images (Fig.
1), as follows:

Figure 1 Proposed expanded anatomical classification of MAs as seen with
conventional fluorescein angiography (left) and AOSLO FA (center) with corresponding
illustrated examples (right). All images have been contrast stretched. Scale bar: 50
μm.

1. Focal bulge were defined as MAs where the combined width of
the associated capillary and MA was less than twice the width of
an adjacent nonaffected region of the capillary. All other
morphologies represented MAs where the combined width of the
associated capillary and MA was more than twice the width of an
adjacent nonaneurysmal region.
2. Saccular MAs were defined as those with asymmetric dilatations
with at least 75% of the total area of the MA on one side of the
central axis of the associated capillary.
3. Fusiform MAs were defined as symmetrically dilated MAs around
their associated capillary, with less than 75% of the total area of
the MA on either side of the associated capillary.
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4. Mixed saccular/fusiform were defined as MAs that could not be
categorized as either saccular or fusiform and it was uncertain
which capillary was associated with it, or when the orientation of
the MA prevented a clear en face view.
5. Pedunculated MAs were asymmetric MAs tethered to their
associated capillary via a tapered narrowing of the lumen.
6. Irregular MAs were saccular, fusiform, or pedunculated with a
nonconvex shape (note: a convex shape is one in which the line
segment defined by any two points within it is fully contained
within the shape). For pedunculated MAs, this definition
excludes the region associated with the tapered narrowing of
the lumen and applies to the remainder of the aneurysm.
As MA features appear different in AOSLO FA and reflectance
images, comparing the two techniques allows inferences to be made
about capillary walls and perfusion. Reflectance AOSLO images
typically reveal the capillary and MA wall, while AOSLO FA shows
exclusively the intraluminal, perfused space. Accordingly, AOSLO
reflectance images were used to locate nonperfused capillaries, which
did not appear in AOSLO FA. With AOSLO FA, the presence of focal
hypofluorescent regions within the otherwise highly fluorescent lumen
of the MA was recorded.
Three trained examiners familiar with the MA classification (Fig. 1)
independently graded all 93 MAs. Based on their classifications,
interexaminer agreement was quantified by calculating the Fleiss'
kappa reliability coefficient.65

Microaneurysm Geometry Quantification
The boundaries of all 93 MAs were manually segmented on the
2D AOSLO FA images using custom MATLAB (Mathworks, Natick, MA)
software. The area, perimeter, feret maximum (longest intraluminal
diameter of MA), and feret minimum (longest diameter perpendicular
to feret maximum) of these boundaries were then calculated (Fig. 2).
Traditionally, MA measurements have frequently used width of the
aneurysm along the direction perpendicular to the associated capillary.
That requires identifying, with certainty, the capillary associated with
each MA and determining the location and extent of that capillary's
connection with the MA, which is not always possible. Feret maximum
(max) and minimum (min) were therefore selected instead, as they
can be more readily measured even when information surrounding the
associated capillary was not clear.
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Figure 2 Adaptive optics scanning light ophthalmoscope fluorescein angiography
image of saccular MA (A) with schematic (B) depicting manual boundary segmentation
of aneurysm in order to determine area (within red dotted lines), perimeter (red
dotted line), feret max (thin arrow), and feret min (thick arrow). Scale bar: 50 μm.

Correlations between metrics, primary ophthalmic diagnoses,
and morphologies were studied by performing a two-step analysis.
First, ANOVA tests were used to test whether there were significant
differences among the metrics derived from each of the conditions and
morphologies. When these tests showed significance (P < 0.05), then
the Scheffe's post hoc test was used to evaluate the differences
between each possible pair of variables examined.
Interobserver segmentation reliability was assessed by having
three trained, independent examiners segment the boundary of 14
randomly selected MAs. Then, intraclass correlation of their
measurements was calculated.
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Results
Patient Demographics
Included in this study were 13 subjects (7 men, 6 women; mean
age 52.8 years; range, 44–68 years) from various racial/ethnic
backgrounds (Table 1). Ophthalmic diagnoses, included diabetic
retinopathy (DR) in six patients, central retinal vein occlusion (CRVO)
in four patients, branch retinal vein occlusion (BRVO) in two patients,
and hypertensive retinopathy (HTN) in one patient. One DR subject
had imaging performed in both eyes.

Table 1 Patient Demographics
PRP, pan-retinal photocoagulation.

Morphology and Pathology
Among the six morphologies, saccular MAs were the most
prevalent, followed by focal bulge, fusiform, mixed, irregular, and
pedunculated, respectively (Table 2). No relationship was seen
between systemic pathology and MA morphology (ANOVA, P = 0.44).
This is consistent with the fact that even when imaging a relatively
small retinal area affected by a single pathology, as shown in Figure 3,
multiple types of MAs were simultaneously present. Interobserver
morphology identification agreement among the three readers was
high (kappa coefficient: 0.88).
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Figure 3 Montage of AOSLO FA images, showing the foveal capillary network and
the foveal avascular zone (FAZ) in the right eye of a subject with hypertension.
Microaneurysms of various size and morphology are visible. Red dots indicate
arterioles. Blue dots indicate venules. Scale bar: 300 μm.

Table 2 Distribution of MA Morphology in Each Pathology Imaged
FB, focal bulge; S, saccular; F, fusiform; M, mixed; P, pedunculated; I, irregular.

Wall and Lumen
Imaging using AOSLO reflectance and FA provide
complementary information about capillary wall and lumen (Fig. 4).
The combination of these imaging modalities revealed that, even
within a single eye affected by a single condition, MAs with varying
degrees of wall thickening and fluorescence could be observed (Fig. 5,
subject with CRVO). Reflectance AOSLO imaging can also reveal
evidence of nonperfused capillaries and obliterated MAs that cannot be
visualized with AOSLO FA imaging alone (Fig. 6).
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Figure 4 Adaptive optics scanning light ophthalmoscope reflectance (A) and
fluorescence (B) images of an irregular MA, nasal to FAZ in Figure 3. The
superposition of these images ([C], with [B] in red) shows the relationship between
wall and lumen. Scale bar: 100 μm.

Figure 5
Reflectance AOSLO images (left) and AOSLO FA (right) of pathologic
regions in a patient with CRVO reveal various states of MAs.
Hyperfluorescent saccular and fusiform MAs (A2) were visualized in a
region without additional pathology (A1). Asterisks ( ...
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Figure 6 Reflectance AOSLO images (left) and AOSLO FA (right) of pathologic
regions in a patient with CRVO reveal various states of MAs. Hyperfluorescent saccular
and fusiform MAs (A2) were visualized in a region without additional pathology (A1).
Asterisks (B1, C1) indicate thickened vascular walls that were seen in both
hyperfluorescent MAs (B2) and a hypofluorescent MA (C2). Arrows (C2, D2) indicate
intraluminal hypofluorescence. Carets (D1, D2) depict location of small MAs that do
not fluoresce on AOSLO FA. Scale bar: 100 μm.

Pathology and MA Geometrical Metrics
Interobserver segmentation reliability among the three readers
was high (intraclass correlation: 0.99). There was a significant
difference between the mean metric values estimated for MAs from
each disease (Table 3) for area (P = 0.05, ANOVA), perimeter (P =
0.04, ANOVA), feret max (P = 0.05, ANOVA), and feret min (P = 0.05,
ANOVA). Further analysis using the Scheffe test, summarized in Table
4, failed to find statistically significant differences between all possible
pairs of systemic pathologies. Statistical significance (P < 0.05) and
near statistical significance (0.05 < P < 0.10) was found only between
CRVO and DR for perimeter, feret max, and feret min. Bubble graphs
(Fig. 7A) show the similarity of quantitative metrics between
pathologies.
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Figure 7 Graphs comparing quantitative metrics (area versus perimeter) for
pathologies (A) and morphologies (B). Center point of each ellipse represents area
mean (x-axis) and perimeter mean (y-axis). Horizontal extent of ellipses determined
by area mean ± SD. Vertical extent of ellipses determined by means of perimeter ±
SD.

Table 3 Pathology Versus MA Quantitative Metrics
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Table 4 Significance Levels (Scheffe's Method) of Quantitative Metrics Between
Pathologies
Y greater than X, statistically significant results bolded, nearly statistically significant
results italicized.

Morphology and MA Geometrical Metrics
Among the six MA morphologies, there were significant
difference between their mean measurements of area (P = 0.0001,
ANOVA), perimeter (P = 0.0001, ANOVA), feret max (P = 0.0001,
ANOVA), and feret min (P = 0.0001, ANOVA) (Table 5). Further
analysis using the Scheffe test (Table 6), found differences between
several pairs of morphologies. Several statistical significant (P < 0.05)
and nearly statistically significant (0.05 < P < 0.10) results were found
for the greater perimeter, feret max, and feret min of pedunculated
and irregular MAs as compared with the other morphologies. Bubble
graphs (Fig. 7B) show the differences of quantitative metrics between
morphologies.
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Table 5 MA Morphology Versus Quantitative Metrics

Table 6 Significance Levels (Scheffe's Method) of Quantitative Metrics Between
Morphologies
Y greater than X, statistically significant results bolded, nearly statistically significant
results italicized.
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Intraluminal Hypofluorescent Regions Versus
Morphology and Quantitative Metrics
Adaptive optics scanning light ophthalmoscope fluorescein
angiography images revealed intraluminal hypofluorescence in 28 out
of 93 (30.1%) MAs (Fig. 1, AOSLO FA fusiform, irregular,
pedunculated; Fig. 4B; Figs. 5C2, 5D2, boxes). This hypofluorescence
was never found in focal bulge MAs (0%), often found in saccular
(25%), fusiform (30%), mixed (50%), and pedunculated (50%), and
most frequently in irregular MAs (75%). Microaneurysms with
hypofluorescent regions were statistically (ANOVA) larger in area
(3086 vs. 1448 μm2, P = 0.0001), perimeter (358 vs. 209 μm, P =
0.0001), feret max (121 vs. 73 μm, P = 0.0001), and feret min (96 vs.
54 μm, P = 0.0001). Although there was no correlation between
systemic pathology and intraluminal hypofluorescence (ANOVA, P =
0.68), there was a strong correlation between the presence or absence
of hypofluorescent regions and the various morphologies (ANOVA, P =
0.0001).

Longitudinal Imaging
A fusiform retinal MA (Fig. 8, left column) in a subject with
hypertensive retinopathy (Fig. 3) was shown to remain unchanged
over a 4-month period (variability of each metric was <±2%
throughout). An adjacent retinal region, imaged only at time 0 and
again after 4 months (Fig. 8, middle column), shows an MA with mixed
shape that dramatically increased in size adjacent to a focal bulge MA
that regressed over the same time. Imaging in a subject with CRVO
before and after anti-VEGF injection shows regression of a mixed MA
that was sustained 3 months later (Fig. 8, right column), while an
adjacent, saccular MA remained stable.
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Figure 8 Left and center columns from one subject with hypertensive retinopathy;
right column from one subject with CRVO. Left column shows AOSLO FA images of a
fusiform MA with stable boundaries at four different imaging sessions over a 4-month
period. Center column follows a mixed MA with growth between time 0 (perimeter:
162 μm, area: 1702 μm2, feret max: 52 μm, feret min: 57 μm) and a second imaging
session at 4 months (perimeter: 230 μm, area: 3676 μm2, feret max: 63 μm, feret
min: 77 μm). The initial image shows a focal bulge MA in the upper right corner that
appears to have regressed by the later session. Right column depicts a region with
saccular (perimeter: 145 μm, area 1415 μm2, feret max: 52 μm, feret min: 39 μm)
and mixed MAs (perimeter: 120 μm, area 1030 μm2, feret max: 40 μm, feret min: 35
μm) imaged before and after anti-VEGF treatment (asterisk indicates treatment had
occurred 3 weeks prior). The mixed MA regressed and continued to be hypofluorescent
at an additional follow-up imaging session while the saccular MA remained stable.
Scale bar: 100 μm. ND, no data.

Discussion
Emerging high-resolution ophthalmic imaging modalities such as
AOSLO and motion contrast OCT are allowing for the visualization of
retinal capillaries with unprecedented transverse and axial resolution.
When used to image retinas affected by vascular disease, AOSLO FA
reveals MAs with great detail, permitting a rich morphologic
categorization scheme. The retinal MA classification presented in this
work is based on the en face, 2D geometry of MAs. It incorporates the
saccular, fusiform, and focal bulge designations proposed in previous
studies,35,52 as well as three additional morphologies discernable with
AOSLO FA. Although our proposed classification is based on AOSLO FA
images, it can be applied to MA images acquired using other
modalities, such as emerging motion contrast techniques.53–55,57,66–69
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This study is limited by the relatively small number of MAs from
13 patients representing a variety of retinal conditions and ophthalmic
treatment histories. Additionally, our analysis attempted to classify
MAs, which are three-dimensional (3D) structures, based solely upon
their 2D, en face appearance. This may have limited our accuracy in
geometrical assessment and will need to be validated using additional
techniques. Three-dimensional imaging modalities with isotropic or
near-isotropic resolution (e.g., AO-OCT) might help to reveal additional
complexities of MA structure, including the nature of mixed
morphology MAs. With all of these limitations considered, the data
resulting from the classification and boundary-derived metrics provides
a number of interesting, early findings.
The first observations derived from statistical testing was that
retinal pathology appeared to place no limits or bias to development of
MA morphology, and that multiple, if not all, MA morphologies can be
found within an adjacent, small area of an individual retina. Thus,
while assaying for the presence of MAs may be a sensitive tool for
following retinal pathology, MA morphology does not seem to have a
propensity for any vasculopathy. Consistent with a previous study in
DR,35 we found that saccular MAs were more prevalent than fusiform
and focal bulge morphologies; this trend applied not only to DR, but
also to the subjects with CRVO, BRVO, and HTN.
An initial ANOVA test indicated that the mean metric values are
different among the retinal conditions tested in this work (P = 0.04–
0.05). However, Scheffe tests used to evaluate differences in metric
values between any pair of pathologies only showed that diabetic MAs
had statistically greater (P < 0.05) mean perimeter and feret max than
CRVO MAs. Thus, based on the metrics used in this study, there are
few obvious differences between MAs due to retinal pathology. In
contrast, the different types of MA morphologies show several, more
statistically significant differences in some cases, including the
relatively greater size of irregular and pedunculated morphologies and
the smaller dimensions of the focal bulge MAs. This is expected as the
classification itself is, like these metrics, based on the MA geometry.
Future studies will be needed to further elaborate on the differences
between the pathologies and morphologies presented here.
A recent study by Wang et al.50 found no correlation between
MA leakage and lumen diameter, wall diameter, or wall thickness,
suggesting that increasing size may not lead to increased risk of
leakage. Ezra et al.36 found that the physical relationship between the
MA radius and associated vessel wall may contribute to leakiness in
Investigative Ophthalmology and Visual Science, Vol. 55, No. 3 (March 2014): pg. 1299-1309. DOI. This article is ©
Association for Research in Vision and Ophthalmology and permission has been granted for this version to appear in ePublications@Marquette. Association for Research in Vision and Ophthalmology does not grant permission for this article
to be further copied/distributed or hosted elsewhere without the express permission from Association for Research in
Vision and Ophthalmology.

20

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

saccular MAs. Several neuroradiology studies have found that
multilobular intracranial aneurysms are more likely to rupture than
unilobular aneurysms,70–72 with one group determining that aneurysm
neck diameter and not overall aneurysm size was more important in
determining the risk of rupture.73 These studies indicate that size alone
is not a sufficient predictor for course of MA pathology, and that other
metrics may need to be identified. It is likely that a deeper
understanding of MA morphology may help determine the risk of
leakiness or rupture.
In addition to determining boundaries, AOSLO FA reveals
intraluminal hypofluorescent regions within some larger MAs. These
regions, not readily observable using conventional FA, appeared in
almost one-third of the imaged MAs, irrespective of the underlying
retinal condition. Notably, such hypofluorescent areas were absent in
focal bulge MAs, but appeared in the majority of the pedunculated and
irregularly shaped ones. Histologic studies have revealed that MA
lumens can be infiltrated by a variety of cell types, ranging from acute
inflammatory cells such as polymorphonuclear cells and monocytes to
red blood cell breakdown products and cellular debris.34 The
hypofluorescence we observed could represent such luminal clots. The
greater luminal surface area of larger MAs like the pedunculated and
irregular morphologies may produce more turbulent blood flow, which
may increase the risk of endothelial injury and the formation or
enlargement of luminal clots. Further studies are needed to elucidate
the relationship between these hypofluorescent regions and advanced
disease.
The complementary information provided by reflectance AOSLO
and FA imaging proved useful in evaluating wall thickness and
identifying nonperfused capillaries and MAs. The different perspective
provided by each imaging modality was helpful in exploring MA natural
progression. This was further examined via imaging a few MAs
longitudinally (Fig. 8), demonstrating that AOSLO FA can show MA
stability, growth, and resolution as well as potentially evaluate the
efficacy of various treatments. The observation of MAs in various
stages of resolution only a few microns apart on the same capillary
illustrates a complex dynamic at play. While the regression of an MA
following anti-VEGF treatment (Fig. 8, right column) is encouraging, it
remains to be seen whether the regression was due to treatment or
just coincident to natural history. As such, monitoring a small sample
of MAs, or their turnover, may not accurately portray all possible
patterns of progression or treatment response. With additional work
beyond this preliminary study, the AOSLO FA may prove to be a
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powerful tool in studying the treatment effects of anti-VEGF
interventions on MAs.
Combining a robust qualitative classification with quantitative
metrics may allow us to better stratify MAs clinically in terms of risk of
leakage or rupture and associated capillary dropout. Clinical
applications of this approach may prove useful in better understanding
microvascular disease progression and help point the way to more
successful treatment regimes.
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